QA: Impact Biomedical INC in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001834105_2024_Impact_Biomedical_INC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Similarly named company. Duplicate? None {'details': [{'other_company': 'Lifecore Biomedical INC DE', 'shared_tokens': {'biomedical'}}]}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001834105, Impact Biomedical INC

  xvar xval
0 AssetsCurrent 332,000
1 IntangibleAssetsNetIncludingGoodwill 25,093,000
2 PropertyPlantAndEquipmentNet 287,000
3 remainder_Assets 18,921,000
4 LiabilitiesCurrent 13,136,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 3,235,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 315,000
9 ResearchAndDevelopmentExpense 1,147,000
10 remainder_Expenses 3,010,000
11 remainder_Revenues 52,000
12 remainder_NetIncome 13,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 44,633,000
1 Liabilities 16,371,000
2 Expenses 4,472,000
3 Revenues 52,000
4 StockholdersEquity 28,262,000
5 NetIncome -4,407,000
6 ComprehensiveNetIncome -4,407,000
7 BaseVar 32,770,500
8 EconomicCapitalRatiobeforeLimitedLiability 1.88
9 EconomicCapitalRatio 2.94

Edgar->Model Mapping

Feature Distribution